Ocular surface changes associated with belantamab mafodotin treatment. Ghalibafan S, Osei KA, Hoffman JE, Sabater AL, et al. Graefes Arch Clin Exp Ophthalmol 2023 May 22. doi: 10.1007/s00417-023-06094.

Read + Share

Amedeo Smart

Independent Medical Education

Ghalibafan S, Osei KA, Hoffman JE, Sabater AL, et al. Ocular surface changes associated with belantamab mafodotin treatment. Graefes Arch Clin Exp Ophthalmol 2023 May 22. doi: 10.1007/s00417-023-06094.
PMID: 37212873